Afecta Pharmaceuticals

Pharmaceutical Manufacturing • Irvine, California, United States • 1-10 Employees

Company overview

Headquarters	2102 Business Center Dr, Irvine, California 92612, US
Phone number	+19492534688
Website	afectapharm.com
NAICS	3254
SIC	283
Keywords	Biotechnology, Nanotechnology, Pharmaceutical, Pediatrics, Clinical Development, Neurology, Ophthalmology, Drug Discovery, Dermatology, Obstetrics, Artificial Intelligence, Oncology, OTC, Gynecology, Small Molecules, Drug Delivery, Medicinal Chemistry, 505(B)(2), Preclinical Development, Multi-Target Drugs
Employees	1-10
Socials

Key Contact at Afecta Pharmaceuticals

Tammy Bryan

Business Development Director

About Afecta Pharmaceuticals

Afecta Pharmaceuticals is an early clinical stage small molecule therapeutics company focused on developing precision medicines to treat chronic disorders and cancers more effectively. Afecta has a validated, proprietary Artificial Intelligence disease/drug targeting platform, PharmetRx®, to discover and optimize Multi-Target drug compounds and formulate them in NanoRx®, our tissue-specific drug delivery technology. Backed by an experienced management team, Afecta is currently advancing AFX-220, our clinically proven lead candidate that effectively treats the disruptive behaviors that occur in children and adolescents with several neurodevelopmental disorders such as Autism, AD/HD, and others. Please visit our website to learn more, register to access our Executive Summary, and receive our latest updates.

Afecta Pharmaceuticals revenue & valuation

Annual revenue	$10,000,000
Revenue per employee	$1,429,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$32,000,000
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Employees by Department

Afecta Pharmaceuticals has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Afecta Pharmaceuticals has never raised funding before.